African burden of disease offers US$40.8 billion pharma opportunity - Africa Health
The growing incidence of Western lifestyle diseases such as cardiovascular disease (CVD), cancer, diabetes and respiratory disease, in addition to infectious and parasitic illness, will present the pharmaceutical industry in Africa with a business opportunity of US$40.8 billion in 2019. A report by Frost & Sullivan shows that there has been a paradigm shift inRead More